Silenced Solutions: The Importance of COVID-19 Therapeutics and the Fight Against Suppression

COVID-19 disease is caused by the Betacoronavirus, SARS-CoV-2. This virus gave rise to 676 million confirmed cases with 6.9 deaths worldwide early 2023. After first appearing in Wuhan, China late 2019, has mutated into seven successive major forms progressive increases infectivity: Alpha, Beta, Delta, Omicron, and Omicron variants BA.4, BA.5, XBB.1.5. Liposomal mRNA vaccines have been developed against Many of these received Emergency-use Authorization, all highly promoted civil authorities media. On other hand, therapeutics developed, but some severely suppressed, even reliance on retracted papers. Our laboratory found that chlorpheniramine maleate, an over-the- counter antihistamine, was active Coronavirus through drug-database searches, molecular modeling, a preliminary retrospective clinical-study. The manuscript described this work rejected several journal editors without peer review, thus providing further direct evidence for suppression small-molecule therapeutics. Epidemiologic study death statistics VAERS database showed 19,710 people lost their lives after vaccination; mortality from common does not sum 20% staggering value. vaccine also responsible significant morbidity. A consensus begun develop among physicians scientists vaccination both result chronic symptoms many people, now called “Long COVID” or “Long-hauler’s syndrome”. Thus, appear be reasonable approach combat disease. In view this, development, testing, approval repurposing imperative, especially as we observe recent due Chlorpheniramine over-the-counter medication, uniquely positioned serve broad-spectrum antiviral SARS-CoV-2 viruses post- pandemic age.